PYC Therapeutics | PYC - Sales Revenues

Stock Price
1.33
Daily Change
0.01 0.38%
Monthly
2.31%
Yearly
9.47%
Q2 Forecast
1.40

PYC Therapeutics reported AUD11.04M in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Avita Medical AUD 17.61M 805K Dec/2025
Medical Developments International AUD 21.57M 12.04M Dec/2025
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025
Pacific Edge NZD 5.94M 4.95M Dec/2025
Paradigm Biopharmaceuticals AUD 284.06K 292.06K Dec/2025
Telix Pharmaceuticals AUD 413.44M 103.71M Dec/2025